Volume 7, Issue 1 (6-2020)                   vacres 2020, 7(1): 17-24 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rashnaei N, Siadat S D, Akhavan Sepahi A, Mirzaee M, Bahramali G, Arab Joshaghani A. Green Synthesized Silver Nanoparticles Using Anise (Pimpinella anisum L.) have Antibacterial Effects. vacres 2020; 7 (1) :17-24
URL: http://vacres.pasteur.ac.ir/article-1-203-en.html
Department of Biology, Borujerd Branch, Islamic Azad University, Borujerd, Iran
Abstract:   (2932 Views)
Introduction: Silver nanoparticles are particles of silver with a size of 1 to 100 nm. These agents have various applications and particularly have received much attention for their antibacterial activity and their use in vaccine production. Among the various methods of synthesizing nanoparticles, using plants due to their high reducing capabilities and also their eco-friendliness is of interest. Methods: Silver nanoparticles (AgNPs) were synthesized using plant anise (Pimpinella anisum L.) and validated using UV-spectrophotometer, transmission electron microscopy and Fourier transform infrared spectroscopy. The produced AgNPs were used against Escherichia coli, Salmonella typhimurium, Staphylococcus aureus and Enterococcus faecalis to examine their antibacterial activities via agar well diffusion, disk diffusion and minimum inhibitory concentration methods. Furthermore, AgNPs were used in combination with three antibiotic disks, namely, Ceftriaxone, Tetracycline and Gentamicin to seek any cooperative effect. Results: Antibacterial effects due to the synthesized AgNPs were observed toward E. coli, S. aureus, S. typhimurium in this order; however, E. faecalis showed the highest resistance to the synthesized AgNPs. Conclusion: AgNPs synthesized using anise had similar antibacterial effects as conventional antibiotics; however with potentially less side effects.
Full-Text [PDF 592 kb]   (964 Downloads)    
Type of Study: Original article | Subject: Other
Received: 2020/07/20

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.